U.S. Markets open in 8 hrs 21 mins

Pfizer Inc. (PFE)

New York Stock Exchange Consolidated Issue - New York Stock Exchange Consolidated Issue Delayed Price. Currency in USD
Add to watchlist
33.24+0.09 (+0.27%)
At close: 4:00PM EDT
People also watch
MRKJNJJPMINTCGE
Full screen
Previous Close33.15
Open33.07
Bid0.00 x 0
Ask0.00 x 0
Day's Range33.07 - 33.39
52 Week Range29.83 - 35.19
Volume16,119,454
Avg. Volume18,231,928
Market Cap197.69B
Beta1.05
PE Ratio (TTM)27.98
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.28 (3.86%)
Ex-Dividend Date2017-08-02
1y Target EstN/A
  • 3 High-Yield Dividend Stocks for Conservative Investors
    Motley Fool8 hours ago

    3 High-Yield Dividend Stocks for Conservative Investors

    These rare gems offer both a high yield and an acceptable level of risk.

  • Reuters12 hours ago

    SAC Capital's Martoma fails to overturn U.S. insider trading conviction

    A divided federal appeals court on Wednesday upheld the insider trading conviction of Mathew Martoma, a former portfolio manager for billionaire Steven A. Cohen's SAC Capital Advisors LP, after the U.S. Supreme Court made such cases easier to pursue. The 2nd U.S. Circuit Court of Appeals in Manhattan found "overwhelming" evidence that a Michigan doctor received financial benefits from providing confidential information to Martoma about a 2008 Alzheimer's drug trial.

  • Pfizer's Ibrance in First-Line Combo Breast Cancer Study
    Zacks15 hours ago

    Pfizer's Ibrance in First-Line Combo Breast Cancer Study

    Pfizer, Inc. (PFE) and six international cancer research groups are collaborating on a combination study to explore the use of Ibrance for first-line treatment of advanced breast cancer.